Schedule 13D ownership disclosure
LIPELLA PHARMACEUTICALS INC.
Common Stock, par value $0.0001 per share · CUSIP: 53630L209
Event date: 2025-04-07
- Filing-level shares
- 212,290.00
- Percent of class
- 4.9%
- Jonathan H. KaufmanReported CIK 0001959250
Shares: 212,290.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-25-000614
- Form type
- SCHEDULE 13D/A
- Filer
- Kaufman Jonathan H
- CIK
- CIK 1959250
- Filed
- Apr 09, 2025
- Reporting period
- Apr 07, 2025
- Description
- Schedule 13D beneficial ownership